Vera J Suman Selected Research

Temozolomide (Temodar)

2/2013	A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
1/2012	Fluctuation of systemic immunity in melanoma and implications for timing of therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vera J Suman Research Topics

Disease

67	Breast Neoplasms (Breast Cancer) 06/2022 - 05/2002
64	Neoplasms (Cancer) 06/2022 - 06/2002
19	Melanoma (Melanoma, Malignant) 01/2021 - 06/2002
9	Disease Progression 01/2019 - 09/2003
7	Triple Negative Breast Neoplasms 06/2022 - 10/2014
7	Multiple Myeloma 01/2022 - 07/2018
5	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2010
5	Neoplasm Metastasis (Metastasis) 10/2018 - 06/2002
3	Hypertension (High Blood Pressure) 08/2017 - 09/2012
3	Fatigue 08/2017 - 10/2010
3	Anaplastic Thyroid Carcinoma 01/2013 - 10/2010
2	Pathologic Complete Response 04/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 02/2005 - 12/2003
2	Warts (Wart) 02/2005 - 12/2003
2	Carcinoma (Carcinomatosis) 08/2002 - 05/2002
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Residual Neoplasm 10/2020

Drug/Important Bio-Agent (IBA)

17	Tamoxifen FDA LinkGeneric 01/2020 - 09/2003
16	Estrogen ReceptorsIBA 01/2021 - 03/2006
13	Aromatase InhibitorsIBA 01/2022 - 09/2003
12	Trastuzumab (Herceptin)FDA Link 01/2021 - 06/2002
11	Paclitaxel (Taxol)FDA LinkGeneric 11/2014 - 10/2005
10	Pharmaceutical PreparationsIBA 06/2022 - 07/2006
8	Letrozole (Femara)FDA LinkGeneric 01/2020 - 09/2003
8	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2017 - 12/2005
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2009
7	Anastrozole (Arimidex)FDA LinkGeneric 01/2020 - 09/2003
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 04/2002
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2014 - 09/2004
6	pazopanib FDA Link 01/2020 - 10/2010
6	exemestane (Aromasin)FDA Link 01/2020 - 09/2003
6	Biomarkers (Surrogate Marker)IBA 01/2018 - 06/2007
6	ErbB Receptors (EGF Receptor)IBA 11/2014 - 09/2004
6	Carboplatin (JM8)FDA LinkGeneric 02/2013 - 01/2005
5	Phenobarbital (Luminal)FDA Link 06/2022 - 06/2011
5	4-hydroxy-N-desmethyltamoxifenIBA 01/2020 - 12/2005
4	Lenalidomide (CC 5013)FDA Link 01/2022 - 07/2018
4	Aromatase (CYP19)IBA 01/2020 - 01/2010
4	Estrogens (Estrogen)FDA Link 01/2020 - 04/2005
4	Hormones (Hormone)IBA 12/2017 - 10/2009
4	VaccinesIBA 01/2016 - 08/2006
3	Androgen Receptors (Androgen Receptor)IBA 06/2022 - 01/2017
3	taxaneIBA 01/2021 - 10/2012
3	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2009
3	Estradiol (Delestrogen)FDA LinkGeneric 01/2020 - 08/2009
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 04/2011
3	human ERBB2 proteinIBA 01/2019 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 01/2009
3	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2004
3	Phosphotransferases (Kinase)IBA 08/2017 - 10/2010
3	Peptides (Polypeptides)IBA 01/2016 - 08/2006
3	ParaffinIBA 12/2014 - 12/2005
3	B 31IBA 11/2014 - 10/2005
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2011 - 08/2006
3	EnzymesIBA 01/2010 - 01/2007
2	Estrogen Receptor betaIBA 02/2022 - 10/2018
2	Bortezomib (Velcade)FDA Link 12/2021 - 07/2010
2	Immunomodulating AgentsIBA 12/2021 - 07/2018
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 01/2016
2	AnthracyclinesIBA 01/2021 - 12/2017
2	IpilimumabIBA 01/2020 - 07/2018
2	Everolimus FDA Link 01/2020 - 01/2018
2	Estrone FDA Link 01/2020 - 01/2010
2	Fulvestrant (Faslodex)FDA Link 01/2020 - 03/2006
2	Interleukin-2 (IL2)IBA 07/2018 - 10/2011
2	Cytostatic AgentsIBA 01/2018 - 12/2017
2	Estrogen Receptor alphaIBA 01/2018 - 11/2017
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 03/2006
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 06/2002
2	AntigensIBA 01/2016 - 12/2008
2	antineoplaston A10 (A 10)IBA 08/2015 - 08/2002
2	A-Form DNA (A-DNA)IBA 12/2014 - 01/2007
2	Temozolomide (Temodar)FDA LinkGeneric 02/2013 - 01/2012
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013 - 09/2012
2	Monatide (IMS 3015)IBA 10/2011 - 08/2006
2	Protein Subunit VaccinesIBA 10/2011 - 08/2006
2	Tyrosine Kinase InhibitorsIBA 10/2010 - 04/2008
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2008 - 08/2006
2	Interleukin-17 (Interleukin 17)IBA 09/2008 - 04/2006
2	KW 2189IBA 01/2007 - 06/2002
2	Megestrol Acetate (Borea)FDA LinkGeneric 05/2005 - 12/2002
2	SuspensionsIBA 12/2002 - 05/2002
1	pomalidomideIBA 12/2021
1	ixazomibIBA 12/2021
1	Proteasome InhibitorsIBA 12/2021
1	InterferonsIBA 01/2021

Therapy/Procedure

44	Therapeutics 06/2022 - 06/2002
21	Drug Therapy (Chemotherapy) 03/2021 - 04/2002
12	Neoadjuvant Therapy 06/2022 - 01/2010
4	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 10/2013
4	Adjuvant Chemotherapy 11/2014 - 10/2005
3	Immunotherapy 01/2021 - 07/2018
3	Aftercare (After-Treatment) 12/2017 - 03/2006
3	Drug Tapering 08/2017 - 10/2010
2	Stem Cell Transplantation 05/2021 - 01/2016
2	Brachytherapy 10/2020 - 08/2002
2	Salvage Therapy 01/2020 - 12/2003
2	Radiotherapy 03/2013 - 02/2005
2	Laparotomy 02/2005 - 12/2003